Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canrenone in Atrial Fibrillation
NCT03536806Phase 4Unknown
- Sponsor
- National Institute of Cardiology
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 4 trial of canrenone in Atrial fibrillation (AFib), sponsored by National Institute of Cardiology. Status: unknown.
02
Drugs
canrenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03536806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03536806.